Form D · Other Technology
Nayya Health, Inc.
New York, NY · CIK 0001914591
Offering snapshot reported Mar 3, 2022 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 17, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2022 | Initial | $14,999,963 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-435669
Source: Form D, filed Mar 3, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sina Chehrazi | Director, Executive |
| Akash Magoon | Director, Executive |
| Victoria Treyger | Director |
| Caroline Xie | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
57 East 11 Th Street, 4 Th Floor
New York, NY, 10003
New York, NY, 10003